Chief Marketing Officer, Contrast Media

Sustain and extend GE Health Care's global leadership in contrast media, and build the marketing engine that carries the business into its next generation of products. The Global Marketing Leader, Contrast Media is the global owner of downstream marketing for the largest portfolio in Pharmaceutical Diagnostics segment, accountable for the global strategy creating the standards, capabilities and operating rhythm that enable regions to execute with speed, consistency and local relevance.

The Contrast Media business operates in a dynamic and growing market, creating significant opportunities to expand customer adoption, strengthen market position and drive profitable growth. The Downstream Marketing function plays a critical role in shaping portfolio strategy, optimising product value, supporting pricing excellence and ensuring market readiness for future launches. As the business balances growth opportunities with supply considerations, this role is responsible for driving customer-centric marketing strategies, prioritising market investments and enabling successful execution across a diverse global footprint to maximise long‑term revenue, profitability and market impact.

This role coordinates a global team spanning product marketing, market research and insights, regional field marketing, marketing enablement, digital and martech. Success requires strong global‑to‑region partnership, clear decision rights and the ability to turn strategy into repeatable playbooks that regions activate.

• Own the global downstream marketing strategy for contrast media across all geographies, translating segment objectives into an integrated brand and demand generation.
• Lead the marketing components of Worldwide Product Planning (WWPP) and Long Term Strategy (LTS) for Contrast Media, directing global market research and competitive intelligence and consolidating it with the voice of region and of the customer.
• Own global brand positioning, segmentation, targeting and messaging architecture; approve regional adaptations and enforce consistency of claims and identity worldwide.
• Provide key inputs into Strategy Reviews and resource planning — market sizing, forecasting, share models and investment requirements — and allocate global downstream budget across brands, regions and channels.
• Own the global defense strategy for a portfolio facing generic and low‑cost competition: value articulation, share retention, volume growth and disciplined price and tender positioning in partnership with market access and pricing.
• Build the evidence‑to‑message chain that sustains premium preference — patient safety, dose and workflow efficiency, supply reliability, sustainability and total cost of care — working with medical affairs and health economics.
• Lead lifecycle management: indication and presentation expansion, packaging and delivery‑system innovation, injector and digital ecosystem tie‑ins, and portfolio rationalisation (LEAN) where SKUs no longer earn their place.
• Own global downstream launch readiness for the new contrast agents entering the portfolio, from pre‑launch market shaping through launch execution and the first years on market.
• Partner with global upstream marketing to build and run the market preparation agenda ahead of approval: disease‑ and pathway‑level education, unmet‑need framing, referral and protocol mapping, KOL and advocacy engagement with medical affairs and professional societies, and payer and reimbursement pathway development with market access.
• Equip commercial teams with the knowledge, materials and tools required at launch, and build a repeatable launch capability that outlasts this launch.
• Continue the shift of the business from a field‑led model to…